Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Flechner

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Surgery|July 22, 1999
Acute colonic pseudo-obstruction (Ogilvie's syndrome) after renal transplantationK J O'Malley, S M Flechner, A Kapoor, et al.
Transplantation Proceedings|January 1, 1998
Kidneys from living donors with renal vascular disease may be safely used for transplantationS M Flechner, B Sankari, S B Streem, et al.
Transplantation|November 15, 1996
Determinants of chronic renal allograft rejection in cyclosporine-treated recipientsS M Flechner, C S Modlin, D P Serrano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipientsS M Flechner, M Glyda, S Cockfield, et al.
Transplantation|February 1, 1987
Exacerbation of cyclosporine toxicity by concomitant administration of erythromycinC W Jensen, S M Flechner, C T Van Buren, et al.
Transplantation Proceedings|April 1, 1986
Long-term results of cyclosporine therapy in recipients of mismatched living related kidneysS M Flechner, C T Van Buren, R H Kerman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplantE L G Heaphy, E D Poggio, S M Flechner, et al.
Transplantation Proceedings|February 1, 1987
Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Transplantation|January 1, 1987
Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Transplantation Proceedings|February 1, 1987
Pretransplant coronary arteriography for diabetic renal transplant recipientsM I Lorber, C T Van Buren, S M Flechner, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Surgery|July 22, 1999
Acute colonic pseudo-obstruction (Ogilvie's syndrome) after renal transplantationK J O'Malley, S M Flechner, A Kapoor, et al.
Transplantation Proceedings|January 1, 1998
Kidneys from living donors with renal vascular disease may be safely used for transplantationS M Flechner, B Sankari, S B Streem, et al.
Transplantation|November 15, 1996
Determinants of chronic renal allograft rejection in cyclosporine-treated recipientsS M Flechner, C S Modlin, D P Serrano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipientsS M Flechner, M Glyda, S Cockfield, et al.
Transplantation|February 1, 1987
Exacerbation of cyclosporine toxicity by concomitant administration of erythromycinC W Jensen, S M Flechner, C T Van Buren, et al.
Transplantation Proceedings|April 1, 1986
Long-term results of cyclosporine therapy in recipients of mismatched living related kidneysS M Flechner, C T Van Buren, R H Kerman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplantE L G Heaphy, E D Poggio, S M Flechner, et al.
Transplantation Proceedings|February 1, 1987
Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Transplantation|January 1, 1987
Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Transplantation Proceedings|February 1, 1987
Pretransplant coronary arteriography for diabetic renal transplant recipientsM I Lorber, C T Van Buren, S M Flechner, et al.
Pageof 12